首页> 美国卫生研究院文献>other >Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma

【2h】

Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma

机译：鉴定可预测转移性肾细胞癌患者舒尼替尼活性的组织微RNA

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo identify tissue microRNAs predictive of sunitinib activity in patients with metastatic renal-cell-carcinoma (MRCC) and to evaluate in vitro their mechanism of action in sunitinib resistance.

机译：目的鉴定可预测转移性肾细胞癌（MRCC）患者舒尼替尼活性的组织微RNA，并在体外评估其对舒尼替尼耐药的作用机制。

著录项

期刊名称 other
作者
Celia Prior; Jose Luis Perez-Gracia; Jesus Garcia-Donas; Cristina Rodriguez-Antona; Elizabeth Guruceaga; Emilio Esteban; Cristina Suarez; Daniel Castellano; Aránzazu González del Alba; Maria Dolores Lozano; Joan Carles; Miguel Angel Climent; Jose Angel Arranz; Enrique Gallardo; Javier Puente; Joaquim Bellmunt; Alfonso Gurpide; Jose Maria Lopez-Picazo; Alvaro Gonzalez Hernandez; Begoña Mellado; Esther Martínez; Fernando Moreno; Albert Font; Alfonso Calvo;
展开▼
作者单位

展开▼
年(卷),期 -1(9),1
年度 -1
页码 e86263
总页数 10
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. 索拉非尼与舒尼替尼一线治疗中国转移性肾细胞癌患者的疗效、安全性和生活质量的比较 [J] . Wen Cai, Wen Kong, Baijun Dong, 癌症（英文版） . 2018,第003期
2. Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma [J] . You Dalsan, Song Sang Hoon, Cho Yong Mee, World journal of urology . 2015,第1期

机译：舒尼替尼治疗转移性肾细胞癌患者中基于组织的分子标记物的预测作用
3. Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma [J] . You Dalsan, Song Sang Hoon, Cho Yong Mee, World journal of urology . 2015,第1期

机译：组织基分子标志物在孙尼碱治疗转移性肾细胞癌治疗中的预测作用
4. Significance of circulating matrix metalloproteinase-9 to tissue inhibitor of metalloproteinases-2 ratio as a predictor of disease progression in patients with metastatic renal cell carcinoma receiving sunitinib [J] . MiyakeH., NishikawaM., TeiH., Urologic oncology . 2014,第5期

机译：循环基质金属蛋白酶9与组织金属蛋白酶2比值作为接受舒尼替尼治疗的转移性肾细胞癌患者疾病进展预测指标的意义
5. Computational Pathology Analysis of TissueMicroarrays Predicts Survival of Renal Clear Cell Carcinoma Patients [C] . Thomas J. Fuchs, Peter J. Wild, Holger Moch, International Conference on Medical Image Computing and Computer-Assisted Intervention;MICCAI 2008 . 2008

机译：组织芯片的计算病理分析预测肾透明细胞癌患者的生存。
6. Methodological Approaches for Conducting Claims-Based Studies in Patients Diagnosed with Metastatic Renal Cell Carcinoma [D] . Chun, Danielle S. 2021

机译：用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
7. Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array [O] . J L Perez-Gracia, C Prior, F Guillén-Grima, 2009

机译：使用人细胞因子芯片鉴定TNF-α和MMP-9作为肾细胞癌患者舒尼替尼活性的潜在基线预测血清标志物
8. Identification of tissue microRNAs predictive of sunitinib activity in patients with metastatic renal cell carcinoma [O] . Prior, C. (Celia), Perez-Gracia, J.L. (José Luis), Garcia-Donas, J. (Jesús), 2014

机译：鉴定可预测转移性肾细胞癌患者舒尼替尼活性的组织微RNA

Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅